Eagle Hopes To Build On Bendamustine Success With Injectable Reformulations
With concentrated, lower-volume injectables, the specialty firm is finding larger patient bases for the cancer drug bendamustine and the muscle relaxant dantrolene.
You may also be interested in...
Shares of Eagle Pharmaceuticals soared over 25% on 17 February on word the company had not only kissed and made up with Teva and its subsidiary Cephalon, but had in fact inked a deal involving a rapid infusion form of bendamustine.
The FDA granted Eagle Pharmaceuticals approval to market its orphan drug Ryanodex (dantrolene sodium) as a treatment for malignant hyperthermia (MH), an inherited and potentially fatal disorder triggered by certain anesthesia agents in genetically susceptible people.
The JVs will develop and commercialize therapeutics for multiple cancer types and autoimmune disorders in China. Novocure partners its Tumor Treating Fields technology with Zai Lab, while Fate and ONO will collaborate on off-the-shelf CAR-T therapies.